Visiongate Blog Dr. Alan Nelson presented on the topic: “How AI and IP Are Making a Difference in Early Cancer Detection” in a podcast sponsored by the Center for Intellectual Property Understanding (CIPU)

Visiongate Blog IPAS Keynote speaker, VisionGate CEO Dr. Alan Nelson, at Northwestern Kellogg School of Management and Center for IP Understanding, Intellectual Property Awareness Summit 2024: AI-Driven Early Cancer Detection: Opportunities and Challenges

Visiongate Blog #11,885,732: MORPHOMETRIC GENOTYPING OF CELLS IN LIQUID BIOPSY USING OPTICAL TOMOGRAPHY

Visiongate Blog VisionGate appoints Neil Bush to its Board of Directors

Visiongate Blog Dr. Ankit Bharat of the Northwestern University Feinberg School of Medicine to join VisionGate’s Medical Advisory Board

Visiongate Blog VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Achieves High Sensitivity in Detecting Both Squamous Cell Carcinoma and Adenocarcinoma

Visiongate Blog VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Detects True Abnormal Cells in Non-cancer Patients with Near 100% Specificity